Treosulfan and Total-marrow Irradiation (TMI) Based Conditioning With Rapamycin-based GvHD Prophylaxis for Allogenic Stem Cell Transplantation in Patients With High-risk Hematological Malignancies.

Conditions:   Irradiated Bone Marrow;   Transplant-Related Hematologic Malignancy;   Leukemia, Acute;   Multiple Myeloma;   Graft Vs Host Disease Interventions:   Drug: Conditioning treatment  " Treosulfan-TMI " ;   Procedure: SCT;   Drug: GvHD prophylaxis Sponsor:   IRCCS San Raffaele Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials